Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis.

Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis (2009) 5.75

The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Med (2011) 4.91

Therapeutic drug monitoring for slow response to tuberculosis treatment in a state control program, Virginia, USA. Emerg Infect Dis (2010) 1.48

Diabetes mellitus and tuberculosis facts and controversies. J Diabetes Metab Disord (2013) 1.43

Geographic differences in time to culture conversion in liquid media: Tuberculosis Trials Consortium study 28. Culture conversion is delayed in Africa. PLoS One (2011) 1.38

Impact of diabetes and smoking on mortality in tuberculosis. PLoS One (2013) 1.36

Diabetes with hypertension as risk factors for adult dengue hemorrhagic fever in a predominantly dengue serotype 2 epidemic: a case control study. PLoS Negl Trop Dis (2012) 1.29

The effect of diabetic control status on the clinical features of pulmonary tuberculosis. Eur J Clin Microbiol Infect Dis (2011) 1.17

Assessing trends and predictors of tuberculosis in Taiwan. BMC Public Health (2012) 1.13

The co-management of tuberculosis and diabetes: challenges and opportunities in the developing world. PLoS Med (2012) 1.09

Smear positive pulmonary tuberculosis among diabetic patients at the Dessie referral hospital, Northeast Ethiopia. Infect Dis Poverty (2013) 1.06

The influence of diabetes, glycemic control, and diabetes-related comorbidities on pulmonary tuberculosis. PLoS One (2015) 1.05

Clinical management of concurrent diabetes and tuberculosis and the implications for patient services. Lancet Diabetes Endocrinol (2014) 1.00

Non-diabetic hyperglycemia exacerbates disease severity in Mycobacterium tuberculosis infected guinea pigs. PLoS One (2012) 0.98

Early Therapeutic Drug Monitoring for Isoniazid and Rifampin among Diabetics with Newly Diagnosed Tuberculosis in Virginia, USA. Tuberc Res Treat (2013) 0.96

Impact of diabetes mellitus on clinical parameters and treatment outcomes of newly diagnosed pulmonary tuberculosis patients in Thailand. Int J Clin Pract (2013) 0.95

Role of diabetes in the prognosis and therapeutic outcome of tuberculosis. Int J Endocrinol (2012) 0.91

Outcome of tuberculosis treatment in patients with diabetes mellitus treated in the revised national tuberculosis control programme in Malappuram District, Kerala, India. PLoS One (2013) 0.90

Relation of leptin, ghrelin and inflammatory cytokines with body mass index in pulmonary tuberculosis patients with and without type 2 diabetes mellitus. PLoS One (2013) 0.89

Tuberculosis and diabetes mellitus - an underappreciated association. Arch Med Sci (2014) 0.88

Diabetes mellitus and risk of all-cause mortality among patients with tuberculosis in the state of Georgia, 2009-2012. Ann Epidemiol (2014) 0.87

Anti-tuberculosis drug concentrations in tuberculosis patients with and without diabetes mellitus. Eur J Clin Pharmacol (2016) 0.86

Diabetes mellitus is associated with cavities, smear grade, and multidrug-resistant tuberculosis in Georgia. Int J Tuberc Lung Dis (2015) 0.85

The role of diabetes co-morbidity for tuberculosis treatment outcomes: a prospective cohort study from Mwanza, Tanzania. BMC Infect Dis (2012) 0.85

Treatment outcome of new smear positive pulmonary tuberculosis patients in Penang, Malaysia. BMC Infect Dis (2014) 0.85

Special populations and pharmacogenetic issues in tuberculosis drug development and clinical research. J Infect Dis (2015) 0.84

Increased severity of tuberculosis in Guinea pigs with type 2 diabetes: a model of diabetes-tuberculosis comorbidity. Am J Pathol (2014) 0.84

Effect of type II diabetes mellitus on treatment outcomes of tuberculosis. Lung India (2014) 0.82

Treatment outcomes in tuberculosis patients with diabetes: a polytomous analysis using Brazilian surveillance system. PLoS One (2014) 0.82

Comparing the factors correlated with tuberculosis-specific and non-tuberculosis-specific deaths in different age groups among tuberculosis-related deaths in Taiwan. PLoS One (2015) 0.80

Statin, calcium channel blocker and Beta blocker therapy may decrease the incidence of tuberculosis infection in elderly Taiwanese patients with type 2 diabetes. Int J Mol Sci (2015) 0.80

Screening patients with type 2 diabetes for active tuberculosis in communities of China. Diabetes Care (2013) 0.79

Changes in glycosylated haemoglobin and treatment outcomes in patients with tuberculosis in Iran: a cohort study. J Diabetes Metab Disord (2014) 0.79

Survival and Predictors of Death after Successful Treatment among Smear Positive Tuberculosis: A Cohort Study. Int J Prev Med (2014) 0.78

Sputum smear conversion and treatment outcomes for tuberculosis patients with and without diabetes in Fiji. Public Health Action (2014) 0.78

Diabetes mellitus is associated with increased mortality during tuberculosis treatment: a prospective cohort study among tuberculosis patients in South-Eastern Amahra Region, Ethiopia. Infect Dis Poverty (2016) 0.77

Diabetes-related tuberculosis in the Middle East: an urgent need for regional research. Int J Infect Dis (2015) 0.77

High mortality in tuberculosis patients despite HIV interventions in Swaziland. Public Health Action (2016) 0.77

The global relationship between the prevalence of diabetes mellitus and incidence of tuberculosis: 2000-2012. Glob J Health Sci (2014) 0.76

Diabetes Reduces the Rate of Sputum Culture Conversion in Patients With Newly Diagnosed Multidrug-Resistant Tuberculosis. Open Forum Infect Dis (2016) 0.76

The complex relationship between human immunodeficiency virus infection and death in adults being treated for tuberculosis in Cape Town, South Africa. BMC Public Health (2015) 0.76

Effect of Diabetes Mellitus on Tuberculosis Treatment Outcome and Adverse Reactions in Patients Receiving Directly Observed Treatment Strategy in India: A Prospective Study. Biomed Res Int (2016) 0.76

Early interventions for diabetes related tuberculosis associate with hastened sputum microbiological clearance in Virginia, USA. BMC Infect Dis (2017) 0.75

Long-term mortality in patients with pulmonary and extrapulmonary tuberculosis: a Danish nationwide cohort study. Clin Epidemiol (2014) 0.75

Glycated hemoglobin screening identifies patients admitted for retreatment of tuberculosis at risk for diabetes in Tanzania. J Infect Dev Ctries (2016) 0.75

Association between diabetes and tuberculosis: case-control study. Rev Saude Publica (2016) 0.75

Network Analysis of Human Genes Influencing Susceptibility to Mycobacterial Infections. PLoS One (2016) 0.75

Prevalence and Impact of Diabetes Mellitus Among Patients with Active Pulmonary Tuberculosis in South Korea. Lung (2017) 0.75

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care (2004) 75.82

Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care (1998) 24.53

American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med (2003) 14.40

Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med (2008) 9.31

Diabetes and tuberculosis: the impact of the diabetes epidemic on tuberculosis incidence. BMC Public Health (2007) 4.13

Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care (2003) 3.45

Glucocorticoid use, other associated factors, and the risk of tuberculosis. Arthritis Rheum (2006) 3.26

The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis. Clin Infect Dis (2007) 3.15

Survival of patients with pulmonary tuberculosis: clinical and molecular epidemiologic factors. Clin Infect Dis (2002) 2.80

Diabetic control and risk of tuberculosis: a cohort study. Am J Epidemiol (2008) 2.65

Common infections in diabetes: pathogenesis, management and relationship to glycaemic control. Diabetes Metab Res Rev (2007) 2.50

Exposure to rifampicin is strongly reduced in patients with tuberculosis and type 2 diabetes. Clin Infect Dis (2006) 2.47

An epidemiological evaluation of risk factors for tuberculosis in South India: a matched case control study. Int J Tuberc Lung Dis (2006) 2.46

Risk factors for pulmonary tuberculosis in Russia: case-control study. BMJ (2005) 2.44

Tuberculosis in poorly controlled type 2 diabetes: altered cytokine expression in peripheral white blood cells. Clin Infect Dis (2008) 2.24

Factors influencing sputum smear and culture conversion time among patients with new case pulmonary tuberculosis. Int J Clin Pract (2007) 2.08

Incidence of pulmonary tuberculosis among diabetics. Tuber Lung Dis (1995) 2.08

Tuberculosis susceptibility of diabetic mice. Am J Respir Cell Mol Biol (2007) 2.03

Impact of type 2 diabetes on manifestations and treatment outcome of pulmonary tuberculosis. Epidemiol Infect (2008) 1.97

Mortality in a large tuberculosis treatment trial: modifiable and non-modifiable risk factors. Int J Tuberc Lung Dis (2006) 1.91

Lower expression of Th1-related cytokines and inducible nitric oxide synthase in mice with streptozotocin-induced diabetes mellitus infected with Mycobacterium tuberculosis. Clin Exp Immunol (2005) 1.64

Impaired immune responses in diabetes mellitus: analysis of the factors and mechanisms involved. Relevance to the increased susceptibility of diabetic patients to specific infections. Diabete Metab (1992) 1.62

Factors changing the manifestation of pulmonary tuberculosis. Int J Tuberc Lung Dis (2005) 1.46

Mycobacterial clearance from sputum is delayed during the first phase of treatment in patients with diabetes. Am J Trop Med Hyg (2008) 1.31

The relationship between diabetes and tuberculosis in Saskatchewan: comparison of registered Indians and other Saskatchewan people. Can J Public Health (2007) 1.27

The impact of age on the demographic, clinical, radiographic characteristics and treatment outcomes of pulmonary tuberculosis patients in Taiwan. Infection (2008) 1.25

Predictors of treatment failure among tuberculosis patients under DOTS strategy in Egypt. East Mediterr Health J (2003) 1.22

Hypodense alveolar macrophages in patients with diabetes mellitus and active pulmonary tuberculosis. Tuber Lung Dis (1999) 1.21

Effects of rifampin on the pharmacokinetics and pharmacodynamics of glyburide and glipizide. Clin Pharmacol Ther (2001) 1.19

Tuberculosis in diabetic patients in Tanzania. Trop Doct (1990) 1.15

[Course of pulmonary tuberculosis in diabetics]. Rev Pneumol Clin (2003) 1.08

Clinical characteristics of pulmonary tuberculosis in adult Pakistani patients with co-existing diabetes mellitus. East Mediterr Health J (2006) 1.08

[Tuberculosis and diabetes mellitus: a longitudinal-retrospective study in a teaching hospital]. Rev Med Chil (1989) 1.03

Effect of improved tuberculosis screening and isoniazid preventive therapy on incidence of tuberculosis and death in patients with HIV in clinics in Rio de Janeiro, Brazil: a stepped wedge, cluster-randomised trial. Lancet Infect Dis (2013) 2.95

Diagnostic accuracy of a urine lipoarabinomannan test for tuberculosis in hospitalized patients in a High HIV prevalence setting. J Acquir Immune Defic Syndr (2009) 2.81

Interferon-γ release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States. Am J Respir Crit Care Med (2014) 2.29

Performance of the microscopic observation drug susceptibility assay in drug susceptibility testing for Mycobacterium tuberculosis. J Clin Microbiol (2002) 2.21

Statistical design of THRio: a phased implementation clinic-randomized study of a tuberculosis preventive therapy intervention. Clin Trials (2007) 2.12

Comparative performance of urinary lipoarabinomannan assays and Xpert MTB/RIF in HIV-infected individuals. AIDS (2014) 2.05

Induction of persistent colitis by a human commensal, enterotoxigenic Bacteroides fragilis, in wild-type C57BL/6 mice. Infect Immun (2009) 2.05

Impact of enhanced tuberculosis diagnosis in South Africa: a mathematical model of expanded culture and drug susceptibility testing. Proc Natl Acad Sci U S A (2008) 2.03

Nocardia veterana as a pathogen in North American patients. J Clin Microbiol (2003) 2.03

Old drugs, new purpose: retooling existing drugs for optimized treatment of resistant tuberculosis. Clin Infect Dis (2012) 1.99

The potential impact of enhanced diagnostic techniques for tuberculosis driven by HIV: a mathematical model. AIDS (2006) 1.79

Smoking and risk of tuberculosis incidence, mortality, and recurrence in South Korean men and women. Am J Epidemiol (2009) 1.78

Interleukin (IL)-12 and IL-23 are key cytokines for immunity against Salmonella in humans. J Infect Dis (2004) 1.71

Body mass index and risk of tuberculosis and death. AIDS (2010) 1.71

Quantitative analysis of a urine-based assay for detection of lipoarabinomannan in patients with tuberculosis. J Clin Microbiol (2010) 1.70

Community-based targeted case finding for tuberculosis and HIV in household contacts of patients with tuberculosis in South Africa. Am J Respir Crit Care Med (2012) 1.66

Molecular epidemiology of tuberculosis in a low- to moderate-incidence state: are contact investigations enough? Emerg Infect Dis (2002) 1.64

Clinical evaluation of the microscopic-observation drug-susceptibility assay for detection of tuberculosis. Clin Infect Dis (2007) 1.62

Diagnostic accuracy of a rapid urine lipoarabinomannan test for tuberculosis in HIV-infected adults. J Acquir Immune Defic Syndr (2014) 1.61

Impact and cost-effectiveness of culture for diagnosis of tuberculosis in HIV-infected Brazilian adults. PLoS One (2008) 1.59

Validation of a hierarchical deterministic record-linkage algorithm using data from 2 different cohorts of human immunodeficiency virus-infected persons and mortality databases in Brazil. Am J Epidemiol (2008) 1.58

Fluoroquinolone resistance in patients with newly diagnosed tuberculosis. Clin Infect Dis (2003) 1.53

Heterogeneity in tuberculosis transmission and the role of geographic hotspots in propagating epidemics. Proc Natl Acad Sci U S A (2012) 1.52

Mycobacterium tuberculosis cell envelope lipids and the host immune response. Cell Microbiol (2004) 1.48

Clinical course and long-term follow-up of patients receiving implantable cardioverter-defibrillators. Heart Rhythm (2006) 1.46

Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study. Arch Intern Med (2006) 1.45

The rapid development of fluoroquinolone resistance in M. tuberculosis. N Engl J Med (2003) 1.37

The implementation of isoniazid preventive therapy in HIV clinics: the experience from the TB/HIV in Rio (THRio) study. AIDS (2010) 1.37

Risk factors for relapse and acquired rifamycin resistance after directly observed tuberculosis treatment: a comparison by HIV serostatus and rifamycin use. Clin Infect Dis (2004) 1.36

Use of the amplified mycobacterium tuberculosis direct test in a public health laboratory: test performance and impact on clinical care. Chest (2007) 1.36

Progression and regression of premalignant cervical lesions in HIV-infected women from Soweto: a prospective cohort. AIDS (2011) 1.32

Cost-effectiveness analysis of the gen-probe amplified mycobacterium tuberculosis direct test as used routinely on smear-positive respiratory specimens. J Clin Microbiol (2003) 1.28

T-SPOT.TB responses during treatment of pulmonary tuberculosis. BMC Infect Dis (2009) 1.27

Enterotoxigenic bacteroides fragilis: a potential instigator of colitis. Inflamm Bowel Dis (2007) 1.27

AIDS-related tuberculosis in Rio de Janeiro, Brazil. PLoS One (2008) 1.21

Comparison of laboratory costs of rapid molecular tests and conventional diagnostics for detection of tuberculosis and drug-resistant tuberculosis in South Africa. BMC Infect Dis (2013) 1.20

Repeated administration of high-dose intermittent rifapentine reduces rifapentine and moxifloxacin plasma concentrations. Antimicrob Agents Chemother (2008) 1.14

Field evaluation of a rapid immunochromatographic test for tuberculosis. J Clin Microbiol (2002) 1.12

The impact of expanded testing for multidrug resistant tuberculosis using genotype [correction of geontype] MTBDRplus in South Africa: an observational cohort study. PLoS One (2012) 1.11

A novel mutation in IFN-gamma receptor 2 with dominant negative activity: biological consequences of homozygous and heterozygous states. J Immunol (2004) 1.11

Sensititre MYCOTB MIC plate for testing Mycobacterium tuberculosis susceptibility to first- and second-line drugs. Antimicrob Agents Chemother (2013) 1.10

Tuberculosis among health care workers in KwaZulu-Natal, South Africa: a retrospective cohort analysis. BMC Public Health (2014) 1.09

Molecular differentiation of Mycobacterium tuberculosis strains without IS6110 insertions. Emerg Infect Dis (2002) 1.06

Cost-effectiveness of community health worker versus home-based guardians for directly observed treatment of tuberculosis in Vitória, Espírito Santo State, Brazil. Cad Saude Publica (2011) 1.04

Clinical evaluation of the microscopic observation drug susceptibility assay for detection of Mycobacterium tuberculosis resistance to isoniazid or rifampin. J Clin Microbiol (2007) 1.03

The health-system benefits and cost-effectiveness of using Mycobacterium tuberculosis direct nucleic acid amplification testing to diagnose tuberculosis disease in the United States. Clin Infect Dis (2013) 1.01

Epidemiological profile of adult patients with tuberculosis and AIDS in the state of Espírito Santo, Brazil: cross-referencing tuberculosis and AIDS databases. J Bras Pneumol (2011) 0.98

Programmatic impact of QuantiFERON-TB Gold In-Tube implementation on latent tuberculosis diagnosis and treatment in a public health clinic. PLoS One (2012) 0.95

Point-of-care Arkansas method for measuring adherence to treatment with isoniazid. Respir Med (2010) 0.95

Immunoglobulin A (IgA) and IgG immune responses against P-90 antigen for diagnosis of pulmonary tuberculosis and screening for Mycobacterium tuberculosis infection. Clin Diagn Lab Immunol (2004) 0.95

Analysis of latent tuberculosis infection treatment adherence among refugees and other patient groups referred to the Baltimore City Health Department TB clinic, February 2009-March 2011. J Immigr Minor Health (2015) 0.94

Tuberculosis and AIDS co-morbidity in Brazil: linkage of the tuberculosis and AIDS databases. Braz J Infect Dis (2009) 0.94

Adherence to isoniazid prophylaxis among HIV-infected children: a randomized controlled trial comparing two dosing schedules. BMC Med (2009) 0.93

Longitudinal analysis of QuantiFERON-TB Gold In-Tube in children with adult household tuberculosis contact in South Africa: a prospective cohort study. PLoS One (2011) 0.91

Factors associated with tuberculosis by HIV status in the Brazilian national surveillance system: a cross sectional study. BMC Infect Dis (2014) 0.91

Estimating the extent of underreporting of mortality among HIV-infected individuals in Rio de Janeiro, Brazil. AIDS Res Hum Retroviruses (2010) 0.89

Coming-of-age of nucleic acid amplification tests for the diagnosis of tuberculosis. Clin Infect Dis (2009) 0.87

Long-term effectiveness of diagnosing and treating latent tuberculosis infection in a cohort of HIV-infected and at-risk injection drug users. J Acquir Immune Defic Syndr (2008) 0.87

Mycobacterium tuberculosis DNA fingerprint clusters and its relationship with RD(Rio) genotype in Brazil. Tuberculosis (Edinb) (2012) 0.86

Specimen dilution improves sensitivity of the amplified Mycobacterium tuberculosis direct test for smear microscopy-positive respiratory specimens. J Clin Microbiol (2007) 0.86

"Proof-of-concept" evaluation of an automated sputum smear microscopy system for tuberculosis diagnosis. PLoS One (2012) 0.85

Evaluation of oral antiseptic rinsing before sputum collection to reduce contamination of mycobacterial cultures. J Clin Microbiol (2011) 0.85

Additive effects of isoniazid preventive therapy and HAART. AIDS (2009) 0.85

Clostridium difficile carriage and serum antitoxin responses in children with inflammatory bowel disease. Inflamm Bowel Dis (2013) 0.85

A comparative assessment of the price, brands and pack characteristics of illicitly traded cigarettes in five cities and towns in South Africa. BMJ Open (2014) 0.85

Prevalence of patients with respiratory symptoms through active case finding and diagnosis of pulmonary tuberculosis among prisoners and related predictors in a jail in the city of Carapicuíba, Brazil. Rev Bras Epidemiol (2010) 0.84

Molecular epidemiology of pleural and other extrapulmonary tuberculosis: a Maryland state review. Clin Infect Dis (2006) 0.83

Timing of therapy for latent tuberculosis infection among immigrants presenting to a U.S. public health clinic: a retrospective study. BMC Public Health (2008) 0.82

Tests for latent tuberculosis infection and isoniazid preventive therapy. Lancet Infect Dis (2012) 0.82

A summary of meeting proceedings on addressing variability around the cut point in serial interferon-γ release assay testing. Infect Control Hosp Epidemiol (2013) 0.82

AIDS-related Kaposi's sarcoma in Brazil: trends and geopolitical distribution. Int J Dermatol (2013) 0.81

Tuberculosis and AIDS co-morbidity in children: linkage of databases from Espirito Santo State, Brazil. J Trop Pediatr (2010) 0.81

Lower levels of interleukin-12 precede the development of tuberculosis among HIV-infected women. Cytokine (2011) 0.81

Cost-effectiveness of different strategies for amplified Mycobacterium tuberculosis direct testing for cases of pulmonary tuberculosis. J Clin Microbiol (2008) 0.81

Prevalent tuberculosis at HIV diagnosis in Rio de Janeiro, Brazil: the TB/HIV in Rio (THRio) Cohort. J Acquir Immune Defic Syndr (2014) 0.80

Human papillomavirus in women with and without HIV-1 infection attending an STI clinic in Vitoria, Brazil. J Int Assoc Physicians AIDS Care (Chic) (2009) 0.80

Cost-effectiveness of novel algorithms for rapid diagnosis of tuberculosis in HIV-infected individuals in Uganda. AIDS (2013) 0.79

Impact of isoniazid preventive therapy for HIV-infected adults in Rio de Janeiro, Brazil: an epidemiological model. J Acquir Immune Defic Syndr (2014) 0.79

A comparative analysis of clinical and molecular factors with the stage of cervical cancer in a Brazilian cohort. PLoS One (2013) 0.79

Physician adherence to guidelines for tuberculosis and HIV care in Rio de Janeiro, Brazil. Braz J Infect Dis (2011) 0.79

Postarrival Tuberculosis Screening of High-Risk Immigrants at a Local Health Department. Am J Public Health (2015) 0.79

Molecular epidemiology of Mycobacterium tuberculosis among South African gold miners. Ann Am Thorac Soc (2015) 0.78

Evaluation of MCM-2 expression in TMA cervical specimens. PLoS One (2012) 0.78

Low-value care for acute sinusitis encounters: who's choosing wisely? Am J Manag Care (2015) 0.77

An evaluation of p16(INK4a) expression in cervical intraepithelial neoplasia specimens, including women with HIV-1. Mem Inst Oswaldo Cruz (2012) 0.76

Serologic Responses in Childhood Pulmonary Tuberculosis. Pediatr Infect Dis J (2017) 0.75

Behavior assessment of women attending a sexually transmitted disease clinic in Vitória, Brazil. An Bras Dermatol (2012) 0.75

Lymphadenitis in an 18-month-old traveler to Mexico. Pediatr Infect Dis J (2007) 0.75

Pulmonary tuberculosis. Pulm Med (2013) 0.75

Cervical cytology and histopathologic abnormalities in women living with AIDS in São Paulo, Brazil. J Acquir Immune Defic Syndr (2011) 0.75